Rani Therapeutics Holdings (RANI) EBITDA Margin (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly EBITDA Margin of 488.23% for Q1 2026, up 649607.0% year-over-year from N/an in Q1 2025, and up 16.43% quarter-over-quarter from 584.19% in Q4 2025.
Rani Therapeutics Holdings (RANI) EBITDA Margin (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' EBITDA Margin history runs 5 years deep, the most recent figure standing at 488.23% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 649607.0% year-over-year to 488.23%; the TTM figure through Mar 2026 stood at 1092.96% (up 318154.0% YoY), while the FY2025 annual figure was 2345.99%, up 284020.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 488.23%, up from 584.19% in the prior quarter.
- The five-year high for EBITDA Margin was 488.23% in Q1 2026, with the low at 6984.3% in Q1 2025.
- The 3-year median for EBITDA Margin is 1019.62% (2025), against an average of 2377.95%.
- The sharpest annual moves came in 2025 and 2026: EBITDA Margin soared 87087 bps in 2025, then soared 649607 bps in 2026.
- Rani Therapeutics Holdings' EBITDA Margin stood at 1455.06% in 2024, then jumped by 60 bps to 584.19% in 2025, then climbed by 16 bps to 488.23% in 2026.
- Business Quant data shows RANI's EBITDA Margin at 488.23% in Q1 2026, 584.19% in Q4 2025, and 6984.3% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | -516.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -516.86% |
| Mar 31, 2026 | -488.23% |
| Dec 31, 2025 | -584.19% |
| Mar 31, 2025 | -6,984.30% |
| Dec 31, 2024 | -1,455.06% |
| Jun 30, 2021 | -268.13% |
| Mar 31, 2021 | -687.57% |
| Dec 31, 2020 | -2,354.29% |
| Sep 30, 2020 | -2,617.59% |
| Jun 30, 2020 | -5,650.00% |